Open Access

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells

  • Authors:
    • Lingjie Bao
    • Melba C. Jaramillo
    • Zhenbo Zhang
    • Yunxi Zheng
    • Ming Yao
    • Donna D. Zhang
    • Xiaofang Yi
  • View Affiliations

  • Published online on: October 16, 2014     https://doi.org/10.3892/mmr.2014.2671
  • Pages: 91-98
  • Copyright: © Bao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cisplatin resistance is a major challenge in the clinical treatment of ovarian cancer, of which the underlying mechanisms remain unknown. The aim of the present study was to explore the role of autophagy in cisplatin resistance in ovarian cancer cells. A2780cp cisplatin‑resistant ovarian carcinoma cells and the A2780 parental cell line, were used as a model throughout the present study. The cell viability was determined using a water soluble tetrazolium salt‑8 assay, and western blot analysis was performed to determine the protein expression levels of microtubule‑associated protein 1 light chain 3 (LC3 I and LC3 II), and Beclin 1. Beclin 1 small interfering (si)RNA and 3‑methyladenine (3‑MA) were used to determine whether inhibition of autophagy may re‑sensitize cisplatin‑resistant cells to cisplatin. The ultrastructural analysis of autophagosomes was performed using transmission electron microscopy, and apoptosis was measured by flow cytometry. In both A2780cp and A2780 cells, cisplatin induced the formation of autophagosomes and upregulated the expression levels of autophagy protein markers, LC3 II and Beclin 1. However, the levels of autophagy were significantly higher in A2780cp cells, as compared with the A2780 cells. The combined treatment of cisplatin with 3‑MA, the autophagy pharmacological inhibitor, increased the cell death rate, but had no effects on apoptosis, as compared with cisplatin treatment alone in A2780cp cells. However, inhibition of autophagy by siRNA knockdown of Beclin 1 expression enhanced cisplatin‑induced cell death and apoptosis. The findings of the present study suggest that autophagy has a protective role in human ovarian cancer cells, and that targeting autophagy may promote chemotherapeutic sensitivity.
View Figures
View References

Related Articles

Journal Cover

January-2015
Volume 11 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Bao L, Jaramillo MC, Zhang Z, Zheng Y, Yao M, Zhang DD and Yi X: Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells. Mol Med Rep 11: 91-98, 2015.
APA
Bao, L., Jaramillo, M.C., Zhang, Z., Zheng, Y., Yao, M., Zhang, D.D., & Yi, X. (2015). Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells. Molecular Medicine Reports, 11, 91-98. https://doi.org/10.3892/mmr.2014.2671
MLA
Bao, L., Jaramillo, M. C., Zhang, Z., Zheng, Y., Yao, M., Zhang, D. D., Yi, X."Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells". Molecular Medicine Reports 11.1 (2015): 91-98.
Chicago
Bao, L., Jaramillo, M. C., Zhang, Z., Zheng, Y., Yao, M., Zhang, D. D., Yi, X."Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells". Molecular Medicine Reports 11, no. 1 (2015): 91-98. https://doi.org/10.3892/mmr.2014.2671